Fjarde Ap-fonden’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.67M Buy
30,600
+10,990
+56% +$2.73M 0.04% 345
2025
Q4
$5.4M Sell
19,610
-300
-2% -$82.1K 0.05% 324
2025
Q3
$5.22M Buy
19,910
+910
+5% +$221K 0.05% 320
2025
Q2
$4.16M Buy
19,000
+3,900
+26% +$834K 0.04% 362
2025
Q1
$3.38M Buy
15,100
+2,000
+15% +$551K 0.04% 369
2024
Q4
$4.29M Sell
13,100
-3,300
-20% -$1.04M 0.04% 367
2024
Q3
$4.92M Buy
+16,400
New +$5.02M 0.05% 343
2024
Q1
$5.58M Buy
14,100
+1,109
+9% +$410K 0.06% 318
2023
Q4
$4.57M Sell
12,991
-300
-2% -$106K 0.06% 349
2023
Q3
$4.99M Sell
13,291
-1,600
-11% -$619K 0.07% 312
2023
Q2
$5.7M Buy
14,891
+3,500
+31% +$1.25M 0.07% 288
2023
Q1
$3.95M Sell
11,391
-2,900
-20% -$847K 0.05% 360
2022
Q4
$3.36M Buy
14,291
+710
+5% +$168K 0.05% 386
2022
Q3
$4.11M Hold
13,581
0.05% 383
2022
Q2
$4.11M Buy
13,581
+2,500
+23% +$813K 0.05% 383
2022
Q1
$4.55M Sell
11,081
-3,900
-26% -$1.53M 0.04% 408
2021
Q4
$7.03M Sell
14,981
-1,600
-10% -$689K 0.06% 318
2021
Q3
$7.04M Sell
16,581
-2,473
-13% -$1.04M 0.06% 309
2021
Q2
$6.84M Buy
19,054
+2,000
+12% +$661K 0.06% 326
2021
Q1
$4.8M Sell
17,054
-1,300
-7% -$372K 0.04% 421
2020
Q4
$5.2M Buy
18,354
+4,400
+32% +$1.23M 0.05% 363
2020
Q3
$3.84M Buy
13,954
+100
+0.7% +$26.5K 0.04% 415
2020
Q2
$3.15M Sell
13,854
-3,446
-20% -$677K 0.04% 437
2020
Q1
$2.63M Sell
17,300
-100
-0.6% -$15.4K 0.04% 419
2019
Q4
$2.62M Buy
+17,400
New +$2.53M 0.03% 514

Other funds holding WST